The aim of this study was to test whether oxygenation in acutely ischemic, collateralized tissue may be improved by normovolemic hemodilution with a solution containing liposome-encapsulated human Hb (HbV). A skin flap model in anesthetized hamsters was used, which consisted of two parts receiving either anatomic or collateral perfusion. Microhemodynamics were investigated with intravital microscopy. Partial tissue oxygen tension was measured with a Clark-type microprobe. Hemodilution was obtained by exchanging 50% of the total blood volume with HbV suspended in 8% human serum albumin (HSA8) or 6% Dextran 70 (Dx70). The size of the vesicles was 276 nm, the P(50) was 22 mmHg, and the Hb concentration of the solutions was 7.5 g/dl. Colloid osmotic pressure and viscosity were 49.9 mmHg and 8.7 cP for HbV-Dx70 and 40.0 mmHg and 2.9 cP for HbV-HSA8, respectively. Hemodilution with HbV-Dx70 led to an increase in microvascular blood flow in the ischemic microvessels to maximally 158% (median, P < 0.01), whereas blood flow remained virtually unchanged after hemodilution with HbV-HSA8. In the ischemic tissue, oxygen tension was improved from 11.9 to 17.0 mmHg (P < 0.01) after hemodilution with HbV-Dx70 but remained virtually unchanged after hemodilution with HbV-HSA8. Our study suggests that the oxygenation in acutely ischemic, collateralized tissue may be improved by normovolemic hemodilution with HbV suspended in Dx70. The effect was achieved by an increase in microcirculatory blood flow related to the rheological properties of the suspending medium.

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpheart.00821.2002DOI Listing

Publication Analysis

Top Keywords

normovolemic hemodilution
12
blood flow
12
oxygenation acutely
8
acutely ischemic
8
ischemic collateralized
8
collateralized tissue
8
tissue improved
8
improved normovolemic
8
tissue oxygen
8
oxygen tension
8

Similar Publications

Article Synopsis
  • The study investigates the incidence of blood transfusions in patients undergoing coronary artery bypass grafting (CABG) using acute normovolemic haemodilution (ANH) over six months.
  • In a cohort of 50 patients, 44% required allogeneic blood transfusions perioperatively, with notable intraoperative and ICU transfusion rates associated with lower haemoglobin levels during surgery and longer surgical times.
  • The findings suggest that managing intraoperative conditions effectively may help reduce the need for blood transfusions and minimize potential postoperative complications.
View Article and Find Full Text PDF

Aim: One of the philosophies of minimally invasive mitral surgery is to enhance recovery after surgery (ERAS). Beyond surgical applications, ERAS applications provide a complementary approach to optimize postoperative course and discharge. In this report, we aim to present institutional protocol for ERAS and its results in patients who underwent totally endoscopic mitral valve surgery (TEMVS).

View Article and Find Full Text PDF
Article Synopsis
  • Myomectomy for Jehovah's Witnesses poses challenges due to their refusal of blood transfusions, requiring careful surgical planning.
  • A patient's successful procedure involved a multidisciplinary effort to conserve blood, utilizing acute normovolemic hemodilution (ANH) and precise surgical techniques.
  • The case emphasizes the need for healthcare providers to respect patients' beliefs while demonstrating ANH as an effective strategy for managing blood loss in complex surgeries.
View Article and Find Full Text PDF

Acute normovolemic hemodilution in cardiac surgery: Rationale and design of a multicenter randomized trial.

Contemp Clin Trials

August 2024

Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.

Article Synopsis
  • The study evaluates acute normovolemic hemodilution (ANH) as a method to decrease the need for red blood cell (RBC) transfusions in patients undergoing elective cardiac surgery, aiming to reduce associated risks and costs.
  • It is a randomized controlled trial conducted in various hospitals, where patients are assigned to either receive ANH before surgery or the best available alternative treatment.
  • The primary goal is to see if ANH lowers the percentage of patients requiring RBC transfusion from 35% to 28%, with secondary outcomes including mortality and complications related to kidney and bleeding issues.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!